BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37665982)

  • 21. RapidBrachyTG43: A Geant4-based TG-43 parameter and dose calculation module for brachytherapy dosimetry.
    Kalinowski J; Enger SA
    Med Phys; 2024 May; 51(5):3746-3757. PubMed ID: 38252746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
    Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
    Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
    Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
    Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical note: A fast and accurate analytical dose calculation algorithm for
    Liu B; Xiong T; Lu J; Li S; Bai X; Zhou F; Wu Q
    Med Phys; 2021 Nov; 48(11):7493-7503. PubMed ID: 34482556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.
    Beaulieu L; Carlsson Tedgren A; Carrier JF; Davis SD; Mourtada F; Rivard MJ; Thomson RM; Verhaegen F; Wareing TA; Williamson JF
    Med Phys; 2012 Oct; 39(10):6208-36. PubMed ID: 23039658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
    Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
    Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
    Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
    Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monte Carlo investigation of dose distribution of uniformly and non-uniformly loaded standard and notched eye plaques.
    Semeniuk O; Malkov V; Chamberland MJP; Weersink RA
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14149. PubMed ID: 37738654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using
    Lee YC; Nik Akhtar M; Kim Y; Jung JW
    Brachytherapy; 2024; 23(3):377-386. PubMed ID: 38336557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A user-oriented procedure for the commissioning and quality assurance testing of treatment planning system dosimetry in high-dose-rate brachytherapy.
    Peppa V; Pantelis E; Pappas E; Lahanas V; Loukas C; Papagiannis P
    Brachytherapy; 2016; 15(2):252-62. PubMed ID: 26727331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H; Davidorf F; Qi Y
    J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL; Leonard KL; Rivard MJ
    Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo dose calculations for high-dose-rate brachytherapy using GPU-accelerated processing.
    Tian Z; Zhang M; Hrycushko B; Albuquerque K; Jiang SB; Jia X
    Brachytherapy; 2016; 15(3):387-398. PubMed ID: 27216118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.
    Rivard MJ; Ballester F; Butler WM; DeWerd LA; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Papagiannis P
    Med Phys; 2017 Sep; 44(9):e297-e338. PubMed ID: 28644913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials.
    Zehtabian M; Sina S; Faghihi R; Meigooni A
    J Appl Clin Med Phys; 2013 May; 14(3):4228. PubMed ID: 23652255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.